Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo
Polycystic kidney disease (PKD) is characterized by the formation of large renal cysts, which lead to a decline in renal function. Here the authors show that genetic and chemical inhibition of TMEM16A largely reduces cyst enlargement in an in vivo model of autosomal dominant PKD.
Guardado en:
Autores principales: | Ines Cabrita, Andre Kraus, Julia Katharina Scholz, Kathrin Skoczynski, Rainer Schreiber, Karl Kunzelmann, Björn Buchholz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7732490990024ecd9bc4ad8f822a3861 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Impact of COVID-19 on Patients With ADPKD
por: Meherzad Kutky, et al.
Publicado: (2021) -
TMEM16K is an interorganelle regulator of endosomal sorting
por: Maja Petkovic, et al.
Publicado: (2020) -
Gating and Regulatory Mechanisms of TMEM16 Ion Channels and Scramblases
por: Son C. Le, et al.
Publicado: (2021) -
Incoercible Vomiting in a Polycystic (ADPKD) Patient on Peritoneal Dialysis
por: Victor Burguera Vion, et al.
Publicado: (2021) -
TMEM16F and dynamins control expansive plasma membrane reservoirs
por: Christine Deisl, et al.
Publicado: (2021)